According to MarketsandMarkets™, The global Drug Discovery Services Market is projected to grow from USD 16.36 billion in 2025 to USD 27.23 billion by 2030, at a CAGR of 10.7% during the forecast period. Growth in this market is driven by increasing R&D investments from pharmaceutical and biopharmaceutical companies, rising demand for cost-effective drug development solutions, and the growing complexity of drug discovery processes.
Browse 577 market data Tables and 64 Figures spread through 450 Pages and in-depth TOC on “Drug Discovery Services Market “.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129
The high cost and resource intensity of in-house drug development are encouraging companies to outsource discovery services to specialized providers. Additionally, increased focus on rare diseases and orphan drugs, along with expanding drug pipelines, is accelerating demand for advanced discovery services. Technological advancements, new drug discovery approaches, and patent expirations are further creating growth opportunities for market players.
Chemistry Services Segment Dominates Market
By type, the chemistry services segment accounted for the largest share of the drug discovery services market in 2024. This dominance is attributed to the widespread adoption of advanced technologies such as combinatorial chemistry and structure-based drug design.
The increasing need for high-quality, safe, and effective drugs is driving demand for analytical and synthetic chemistry services. These services play a critical role in early-stage drug development, enabling efficient identification and optimization of promising drug candidates.
Biologics Segment Registers Fastest Growth
Based on drug type, the biologics segment is expected to witness the fastest growth during the forecast period. Biopharmaceutical companies are increasingly focusing on biologics for the treatment of complex diseases across therapeutic areas such as oncology, immunology, and rare disorders.
The complexity, high development costs, and specialized manufacturing requirements associated with biologics are encouraging companies to outsource discovery and development activities to experienced service providers. This trend is significantly contributing to segment growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=138732129
Asia Pacific Emerges as High-Growth Region
The Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. Growth in this region is driven by the rapid expansion of pharmaceutical and biopharmaceutical industries, increasing number of contract research organizations (CROs), and favorable regulatory environments in several countries.
While North America currently dominates the market due to the presence of established CROs and high R&D spending, Asia Pacific is becoming a key hub for outsourced drug discovery services, offering cost advantages and strong technical capabilities.
Competitive Landscape
Key players operating in the drug discovery services market include Charles River Laboratories (US), Thermo Fisher Scientific Inc. (US), WuXi AppTec (China), Pharmaron (China), and Labcorp (US), among others.
These companies are focusing on expanding service portfolios, leveraging advanced technologies, and forming strategic partnerships to strengthen their global market position and meet the growing demand for outsourced drug discovery solutions.
Related Reports:
Vaccines Market – Global Forecast to 2030
Artificial Intelligence in Drug Discovery Market – Global Forecast to 2029
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/drug-discovery-services-market-138732129.html
